Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Halland Osteoarthritis (HALLOA) Cohort Study - a Five-year Observational Longitudinal Study With Focus on Metabolic Osteoarthritis

NCT04928170 is registered in ClinicalTrials.gov with FoU Center Spenshult as lead sponsor.

NCT NCT04928170
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04928170 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Halland Osteoarthritis (HALLOA) Cohort Study - a Five-year Observational Longitudinal Study With Focus on Metabolic Osteoarthritis
Lead sponsor
FoU Center Spenshult
Phase
Observational
Overall status
Active, not recruiting
Start date
November 1, 2016
Completion date
December 1, 2024
Enrollment
312 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis generalized, osteoarthritis hand, osteoarthritis, knee